Abstract
3D pharmacophore modeling is an important computational methodology for ligand-enzyme binding interactions in drug discovery. More specifically, a consensus pharmacophore model derived from diverse ligands is a key determinant upon which the prediction power of computational models is based for designing novel ligands. In this work, by merging the important pharmacophore features based on four classes of covalent FAAH ligands, and then integrating the exclusion volume spheres derived from the crystal structure, we created for the first time an integrated FAAH pharmacophore model to describe the ligand-enzyme binding interactions. This new integrated FAAH pharmacophore model can correctly predict the covalent ligand binding mode, which correlates with the SAR data. The study is expected to provide insights into novel covalent ligand-FAAH binding interactions, and facilitate the design of covalent ligands against FAAH.
Keywords: Covalent, fatty acid amide hydrolase (FAAH), pharmacophore, docking
Current Computer-Aided Drug Design
Title:Integrated Ligand Based Pharmacophore Model Derived from Diverse FAAH Covalent Ligand Classes
Volume: 8 Issue: 4
Author(s): Lingling Shen, Hongwei Huang, Alexandros Makriyannis and Luke S. Fisher
Affiliation:
Keywords: Covalent, fatty acid amide hydrolase (FAAH), pharmacophore, docking
Abstract: 3D pharmacophore modeling is an important computational methodology for ligand-enzyme binding interactions in drug discovery. More specifically, a consensus pharmacophore model derived from diverse ligands is a key determinant upon which the prediction power of computational models is based for designing novel ligands. In this work, by merging the important pharmacophore features based on four classes of covalent FAAH ligands, and then integrating the exclusion volume spheres derived from the crystal structure, we created for the first time an integrated FAAH pharmacophore model to describe the ligand-enzyme binding interactions. This new integrated FAAH pharmacophore model can correctly predict the covalent ligand binding mode, which correlates with the SAR data. The study is expected to provide insights into novel covalent ligand-FAAH binding interactions, and facilitate the design of covalent ligands against FAAH.
Export Options
About this article
Cite this article as:
Shen Lingling, Huang Hongwei, Makriyannis Alexandros and S. Fisher Luke, Integrated Ligand Based Pharmacophore Model Derived from Diverse FAAH Covalent Ligand Classes, Current Computer-Aided Drug Design 2012; 8(4) . https://dx.doi.org/10.2174/157340912803519615
DOI https://dx.doi.org/10.2174/157340912803519615 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Risks of Self-Medication Practices
Current Drug Safety The Immune System Regulation in Sepsis: From Innate to Adaptive
Current Protein & Peptide Science Clinical Characteristics and CT Imaging Features of COVID-19 on Admission: A Retrospective Study
Current Medical Imaging Synthesis and Anti-HIV Activity of Bi-Functional Triterpene Derivatives
Letters in Drug Design & Discovery State of Research Tracks and Property Protection of Photodynamic Sensitizers and Delivery Methodologies
Recent Patents on Chemical Engineering Computer-Aided Drug Design Methodologies Toward the Design of Anti-Hepatitis C Agents
Current Topics in Medicinal Chemistry Metagenome Assembly Validation: Which Metagenome Contigs are Bona Fide?
Current Bioinformatics Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19
Protein & Peptide Letters Anti-Tuberculosis
Current Bioactive Compounds In Vitro Data of Current Therapies for SARS-CoV-2
Current Medicinal Chemistry Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases
Current Protein & Peptide Science Recent Patents in Diagnosis and Treatment for Inborn Errors of Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Pharmacophore Based Drug Design Approach as a Practical Process in Drug Discovery
Current Computer-Aided Drug Design Studies on Anticancer Activities of Lactoferrin and Lactoferricin
Current Protein & Peptide Science Potential Role of Hydrogen Sulfide in the Pathogenesis of Vascular Dysfunction in Septic Shock
Current Vascular Pharmacology Application of Molecular Imaging Technologies in Antitumor Drug Development and Therapy
Current Pharmaceutical Design Use of Mathematical Structural Invariants in Analyzing Combinatorial Libraries: A Case Study with Psoralen Derivatives
Current Computer-Aided Drug Design New Lead Generation Strategies for Protein Kinase Inhibitors - Fragment Based Screening Approaches
Mini-Reviews in Medicinal Chemistry The Evolution of Histamine H3 Antagonists/Inverse Agonists
Current Topics in Medicinal Chemistry Intracellular Signaling by Phospholipase D as a Therapeutic Target
Current Pharmaceutical Biotechnology